<<

M i l e s to n e s

DOI: m ilestone 2 10.1038/nrg2246 The dawn of recombinant DNA

The ability to make recombinant DNA molecules is the cornerstone CORBIS of modern molecular . Yet 40 years ago, it was hardly a conceivable accomplishment. In the 1960s, biologists had realized that DNA recombination happens in the cell — for example, when breaks caused by ultraviolet irradiation are repaired — and the search for an that could join DNA molecules was on. The breakthrough came at the beginning of 1967, when Martin Gellert at the National Institutes of Health showed that extracts could convert λ phage DNA ‘hydrogen- bonded circles’ into a covalently circular form. Within 6 months, Gellert and three other groups inde- fragments from two experiments. However, the founda- pendently purified the enzymatic (each conferring resistance to one tion had been laid and progress soon activity, which formed phosphodi- antibiotic), joined them using DNA resumed. ester bonds between DNA ends ligase and applied the mixture to Veronique Kiermer, Chief Editor, held by hydrogen-bond pairing in a transform E. coli. As they had hoped, Nature Methods double-stranded configuration. a fraction of the transformed bacteria DNA ligase, which was the first became resistant to both antibiotics ORIGINAL PAPERS Gellert, M. Formation of covalent circles of λ DNA by E. coli ingredient for making recombinant while carrying a single hybrid extracts. Proc. Natl Acad. Sci. USA 57, 148–155 DNA, was then at hand, but . Not only had they demon- (1967) | Cohen, S. N., Chang, A. C. Y. & Hsu, L. other ingredients, like restriction strated that bacterial plasmids con- Nonchromosomal antibiotic resistance in bacteria: genetic transformation of E. coli by , (see Milestone 4) remained structed were functional in R-factor DNA. Proc. Natl Acad. Sci. USA 69, to be discovered. Another key con- bacteria, but they had also described 2110–2114 (1972) | Cohen, S. N., Chang, A. C. Y., Boyer, H. W. & Helling, R. B. Construction of cept was the use of plasmids as vec- the first plasmid vector. biologically functional bacterial plasmids in vitro. tors for shuttling DNA into bacteria. Meanwhile, had devised Proc. Natl Acad. Sci. USA 70, 3240–3244 (1973) | Stanley Cohen, who was studying a similar experiment to transfer Jackson, D. A., Symons, R. H. & Berg, P. Biochemical method for inserting new genetic information the role of plasmids in bacterial foreign DNA into mammalian cells, into DNA of simian 40. Proc. Natl Acad. Sci. resistance to antibiotics at Stanford using the tumour virus SV40 as a USA 69, 2904–2909 (1972) University, first worked out a ‘trans- vector. In 1972, he made a hybrid FURTHER READING Gefter, M. L., Becker, A. & Hurwitz J. The enzymatic repair of DNA, I. formation’ method to make bacteria molecule in vitro by inserting λ Formation of circular λ DNA. Proc. Natl Acad. Sci. take up purified plasmid DNA. phage sequences into SV40. These USA 58, 240–247 (1967) | Olivera, B. M. & Lehman, I. R. Linkage of polynucleotides through Then, in 1973, Cohen and his reports immediately raised concerns, phosphodiester bonds by an enzyme from E. coli. Stanford colleague Annie Chang, in as E. coli, which is a natural habitant Proc. Natl Acad. Sci. USA 57, 1426–1433 (1967) | collaboration with and of the human gut, could now carry Weiss, B. & Richardson, C. C. Enzymatic breakage and joining of deoxyribonucelic acid. Proc. Natl Robert Helling at the University of hybrid DNA molecules containing Acad. Sci. USA 57, 1021–1028 (1967) | California in San Francisco, reported SV40 oncogenes or other potentially Zimmerman, S. B., Little, J. W., Oshinsky, C. K. & the first in vitro construction of a harmful sequences. These fears led Gellert, M. Enzymatic joining of DNA strands: a novel reaction of diphosphopyridine . bacterial plasmid. Using the restric- the community to a self-imposed Proc. Natl Acad. Sci. USA 57, 1841–1848 (1967) tion enzyme EcoRI, they generated moratorium on recombinant DNA

nature MILESTONES | DNA technologies november 2007 |  © 2007 Nature Publishing Group